Stämm

We've developed accessible, plug-&-play manufacture solutions, allowing an automatized, continuous, and more efficient production of biologics and CGT while managing media conditions. We are reinventing biomanufacturing by providing an alternative to the known biomass production.

Our products and solutions offer a complete optimization of the entire biomanufacturing workflow, encouraging free flow of information between R&D, manufacturing, analytical, quality, engineering & sourcing.

We have developed the first bioreactor of continuous production for monoclonal antibodies and cell therapies leveraging microfluidics for improving the cell conditions and 3D printing for adaptability.